Rosiglitazone treatment restores renal dopamine receptor function in obese zucker rats

Hypertension

Volumn 40, Issue 6, 2002, Pages 880-885

  Umrani, Dhananjay N ^a   Banday, Anees A ^a   Hussain, Tahir ^a   Lokhandwala, Mustafa F ^a  

^a UNIVERSITY OF HOUSTON   (United States)

Author keywords

Hyperinsulinism; Obesity; Rats, Zucker; Receptors, dopamine

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); DOPAMINE RECEPTOR; GLUCOSE; INSULIN; ROSIGLITAZONE; SODIUM;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; EPITHELIUM CELL; GLUCOSE BLOOD LEVEL; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; KIDNEY PROXIMAL TUBULE; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN FUNCTION; SODIUM EXCRETION;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANIMALS; BINDING, COMPETITIVE; BLOOD GLUCOSE; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; EPITHELIAL CELLS; GLUCOSE; HYPERINSULINISM; HYPOGLYCEMIC AGENTS; INSULIN; KIDNEY; KIDNEY TUBULES, PROXIMAL; MALE; NA(+)-K(+)-EXCHANGING ATPASE; OBESITY; RATS; RATS, ZUCKER; RECEPTORS, DOPAMINE D1; THIAZOLES; THIAZOLIDINEDIONES;

EID: 0036899151     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000039963.01288.D3     Document Type: Article

References (38)

1. Hussain T, Lokhandwala MF. Renal dopamine receptor function in hypertension. Hypertension. 1998;32:187-197.
2. Felder CC, McKelvey AM, Gitler MS, Eisner GM, Jose PA. Dopamine receptor subtypes in brush border and basolateral membrane. Kidney Int. 1989;36:183-193.
3. Hegde SS, Jadhav AL, Lokhandwala MF. Role of kidney dopamine in the natriuretic response to volume expansion in rats. Hypertension. 1989;13: 828-834.
4. +-exchanger activity in renal BBMV by stimulation of adenylyl cyclase. Am J Physiol. 1990;259:F297-F303.
5. Vyas SJ, Eichberg J, Lokhandwala MF. Characterization of receptors involved in dopamine induced activation of phospholipase-C in rat renal cortex. J Pharmacol Exp Ther. 1992;260:134-139.
6. Hussain T, Lokhandwala MF. Renal dopamine-I receptor coupling with Gs and Gq/11 proteins in spontaneously hypertensive rats. Am J Physiol. 1997;272:F399-F346.
7. Gesek FA, Schoolwerth AC. Hormonal interaction with the proximal Na,H-exchanger. Am J Physiol. 1990;258:F514-F521.
8. Bertorello A, Hokfelt T, Goldstein M, Aperia A. Proximal tubule Na,K-ATPase activity is inhibited during high salt diet: Evidence for dopamine-mediated effect. Am J Physiol. 1988;254:F795-F801.
9. Chen CJ, Lokhandwala MF. Inhibition of Na,K-ATPase in rat renal proximal tubules by dopamine involved D1-like dopamine receptor activation. Naunyn Schmiedbergs Arch Pharmacol. 1993;347:289-295.
10. Felder RA, Seikaly MG, Cody P, Eisner GM, Jose PA. Attenuated renal response to dopaminergic drugs in spontaneously hypertensive rats. Hypertension. 1990;15:560-569.
11. Chen CJ, Lokhandwala MF. An impairment of tubular DA-1 receptor function as a causative factor for diminished natriuresis to volume expansion in spontaneously hypertensive rats. Clin Exp Hypertens. 1992; 14:615-628.
12. Kinoshita S, Sidhu A, Felder RA. Defective dopamine-1 receptor adenylyl cyclase coupling in the proximal tubule from spontaneously hypertensive rats. J Clin Invest. 1989;84:1849-1856.
13. Gesek FA, Schoolwerth AC. Hormone response to proximal Na, H-exchanger in spontaneously hypertensive rats. Am J Physiol. 1991;261: F526-F536.
14. Chen CJ, Beach RE, Lokhandwala MF. Dopamine fails to inhibit renal tubular sodium pump in hypertensive rats. Hypertension. 1993;21: 364-372.
15. Felder RA, Sanada H, Xu J, Yu PY, Wang Z, Watanabe H, Asico LD, Wang W, Zheng S, Yamaguchi I, Williams SM, Gainer J, Brown NJ, Hazen-Martin D, Wong LJ, Robillard JE, Carey RM, Eisner GM, Jose PA. G protein-coupled receptor kinase 4 gene variants in human essential hypertension. Proc Natl Acad Sci. U S A. 2002;99:3872-3877.
16. Hussain T, Beheray SA, Lokhandwala MF. Defective dopamine receptor function in proximal tubules of obese Zucker rats. Hypertension. 1999; 34:1091-1096.
17. Hussain T, Becker M, Beheray S, Lokhandwala MF. Dopamine fails to inhibit Na,H-exchanger in proximal tubules of obese Zucker rats. Clin Exp Hypertens. 2001;23:591-601.
18. Zucker LM, Zucker TF. Fatty, a new mutation in the rat. J Hered. 1961;52:275.
19. Hu ZW, Shi XY, Hoffman BB. Insulin and insulin-like growth factor 1 differentially induce alphal-adrenergic receptor subtype expression in rat vascular smooth muscle cells. J Clin Invest. 1996;98:1826-1834.
20. 1 receptor gene expression by posttranscriptional mechanisms. Circulation. 1998;98:2453-2460.
21. Valiquette M, Parent S, Loisel TP, Bouvier M. Mutation of tyrosine-141 inhibits insulin-promoted tyrosine phosphorylation and increased responsiveness of the human beta 2-adrenergic receptor. EMBO J. 1995;14: 5542-5549.
22. Segers O, Anckaert E, Gerlo E, Dupont AG, Somers G. Dopaminesodium relationship in type 2 diabetic patients. Diabetes Res Clin Prac. 1996;34:89-98.
23. Barman JA, Plosker GL. Rosiglitazone. Drugs. 1999;57:921-930.
24. Walker AB, Chattington PB, Buckingham RE, Williams G. The thiazolidinedione rosiglitazone (BRL-49653) lowers blood pressure and protects against impairment of endothelial function in Zucker fatty rats. Diabetes. 1999;48:1448-1453.
25. Rosenberg MR, Michalopoulos G. Kidney proximal tubular cells isolated by collagenase perfusion grow in defined media in the absence of growth factors. J Cell Physiol. 1987;131:107-113.
26. Asghar M, Hussain T, Lokhandwala MF. Higher basal serine phosphorylation of D1A receptors in proximal tubules of old Fischer 344 rats. Am J Physiol. 2002;283:F350-F355.
27. Segers O, Dupont AG, Gerlo E, Somers G. Urinary sodium and dopamine excretion: Role of hyperinsulinemia in renal dopamine production. Med Sci Res. 1996;24:571-572.
28. Shigetomi S, Yamada Z, Ishii H, Sanada H, Watanabe H, Fukuchi S. Dopaminergic activity and endorenal dopamine synthesis in non-insulin dependent diabetes mellitus. Hypertens Res. 1995;18:S125-S130.
29. Tsuchida H, Imai G, Shima Y, Satoh T, Owada S. Mechanism of sodium load-induced hypertension in non-insulin dependent diabetes mellitus model rats: Defective dopaminergic system to inhibit Na,K-ATPase activity in renal epithelial cells. Hypertens Res. 2001;24:127-135.
30. Salkovic M, Sabolic I, Lackovic Z. Striatal dopaminergic D1 and D2 receptors after intracerebroventricular application of alloxan and streptozotocin in rat. J Neural Transm Gen Sect. 1995;100:137-145.
31. Salkovic M, Lackovic Z. Brain D1 dopamine receptor in alloxan-induced diabetes. Diabetes. 1992;41:1119-1121.
32. Satoh T, Cohen HT, Katz AI. Different mechanisms of renal Na,K-ATPase regulation by protein kinases in the proximal and distal nephron. Am J Physiol. 1993;265:F399-F405.
33. Alosno-Galicia M, Brands MW, Zappe DH, Hall JE. Hypertension in obese Zucker rats: Role of angiotensin II and adrenergic activity. Hypertension. 1996;28:1047-1054.
34. Kurtz TW, Morris RC, Pershadsingh HA. The Zucker fatty rat as a genetic model of obesity and hypertension. Hypertension. 1989;13: 896-901.
35. Zeigler DW, Patel KP. Reduced renal responses to an acute saline load in obese Zucker rats. Am J Physiol. 1991;261:R712-718.
36. Frieberg CE, Van Buren M, Bijlsma J. Insulin increases sodium reabsorption in diluting segment in humans: Evidence for indirect mediation through hypokalemia. Kidney Int. 1991;40:251-256.
37. Baum M. Insulin stimulates volume absorption in the rabbit proximal convoluted tubule. J Clin Invest. 1987;79:1104-1109.
38. Tallam LS, Jandhyala BJ. Significance of exaggerated natriuresis after angiotensin AT1 receptor blockade or angiotensin-converting enzyme inhibition in obese Zucker rats. Clin Exp Pharmacol Physiol. 2001;28: 433-440.